We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.11B
AUM Growth
+$194M
Cap. Flow
+$818M
Cap. Flow %
38.75%
Top 10 Hldgs %
58.11%
Holding
879
New
298
Increased
119
Reduced
90
Closed
306

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Consumer Discretionary 11.05%
3 Financials 5.53%
4 Technology 3.61%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
576
CALL
Agios Pharmaceuticals
AGIO
$1.95B
-68,100
Closed -$155K
AGIO icon
577
Agios Pharmaceuticals
AGIO
$1.95B
-3,651
Closed -$201K
AGIO icon
578
PUT
Agios Pharmaceuticals
AGIO
$1.95B
-68,400
Closed -$68K
AL
579
CALL
DELISTED
Air Lease Corp
AL
-10,500
Closed -$23K
ALKS icon
580
Alkermes
ALKS
$8.29B
-23,385
Closed -$573K
ALLK
581
CALL
DELISTED
Allakos
ALLK
-46,200
Closed -$109K
AMED
582
CALL
DELISTED
Amedisys
AMED
-23,900
Closed -$26K
AMGN icon
583
CALL
Amgen
AMGN
$226B
-6,000
Closed -$240K
AMGN icon
584
PUT
Amgen
AMGN
$226B
-9,600
Closed -$12K
ARKG icon
585
PUT
ARK Genomic Revolution ETF
ARKG
$1.78B
-55,900
Closed -$4K
ARWR icon
586
CALL
Arrowhead Research
ARWR
$12.5B
-2,200
Closed -$8K
ARWR icon
587
PUT
Arrowhead Research
ARWR
$12.5B
-15,900
Closed -$151K
ASPN icon
588
CALL
Aspen Aerogels
ASPN
$522M
-69,700
Closed -$401K
FRMM
589
CALL
Forum Markets
FRMM
$83.2M
-4
Closed -$17K
FRMM
590
Forum Markets
FRMM
$83.2M
-20
Closed -$744K
FRMM
591
PUT
Forum Markets
FRMM
$83.2M
-3
Closed -$6K
AUPH icon
592
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
-13,000
Closed -$25K
AZUL
593
DELISTED
Azul
AZUL
-10,000
Closed -$264K
BARK icon
594
BARK
BARK
$96.7M
-6,155
Closed -$1.36M
BARK icon
595
PUT
BARK
BARK
$96.7M
-6,155
Closed -$515K
BBIO icon
596
CALL
BridgeBio Pharma
BBIO
$16.6B
-26,000
Closed -$47K
BCRX icon
597
BioCryst Pharmaceuticals
BCRX
$2.51B
-14,960
Closed -$237K
BCRX icon
598
PUT
BioCryst Pharmaceuticals
BCRX
$2.51B
-40,500
Closed -$34K
BEAM icon
599
CALL
Beam Therapeutics
BEAM
$2.82B
-8,000
Closed -$444K
BEAM icon
600
PUT
Beam Therapeutics
BEAM
$2.82B
-4,700
Closed -$8K

Similar funds

Cowen and Company's Q3 2021 Portfolio in Review

As of Q3 2021, Cowen and Company held 879 positions worth $2.11B, up 10% from $1.92B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Cowen and Company deployed $818M of net new capital in Q3 2021, opening 298 new positions and adding to 119 existing holdings. Its largest new stake was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Nice, an estimated $7.38M trimmed.

  • Cowen and Company's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.
  • Cowen and Company added most to FTAI Aviation in Q3 2021, an estimated $42.9M increase.
  • Cowen and Company's biggest Q3 2021 reduction was Nice, cutting an estimated $7.38M.
  • Cowen and Company fully exited Foley Trasimene Acquisition Corp. in Q3 2021, selling an estimated $15.1M.
  • Cowen and Company's ten largest holdings make up 58% of its $2.11B portfolio in Q3 2021.
  • Cowen and Company opened 298 new positions and closed 306 in Q3 2021.
  • Cowen and Company's portfolio value rose 10% quarter-over-quarter to $2.11B.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.